Document is current
Any future updates will be listed below
-
Authors
Li, Kan Yan Chloe https://orcid.org/0000-0001-7737-2118
Dejea, Hector https://orcid.org/0000-0003-2584-9812
De Winne, Koen https://orcid.org/0000-0002-4848-0803
Bonnin, Anne https://orcid.org/0000-0001-5537-8682
D’Onofrio, Valentino https://orcid.org/0000-0003-3828-0442
Cox, Janneke A. https://orcid.org/0000-0003-1040-6381
Garcia-Canadilla, Patricia https://orcid.org/0000-0002-0223-1617
Lammens, Martin https://orcid.org/0000-0002-3881-6692
Cook, Andrew C. https://orcid.org/0000-0001-5079-7546
Bijnens, Bart https://orcid.org/0000-0003-3130-6937
Dendooven, Amélie https://orcid.org/0000-0002-9900-7952
-
Funding
Funding for this research was provided by:
British Heart Foundation (BHF FS/4yPhD/F/20/34134)
ETH Zürich Foundation (#2017-303)
Fonds Wetenschappelijk Onderzoek (G0G2620N, G0G2620N)
Generalitat de Catalunya (2018-BP-00201)
Spanish Cardiac Society (SEC/FEC-INV-CLI 20/028)
- License Information
-
More Information
Article History
Accepted: 15 June 2023
First Online: 31 July 2023
Declarations
:
: The authors declare that there is no conflict of interest.
: Samples were collected at Jessa Hospital in Hasselt (Belgium) in the context of a prospective observational cohort study which received ethical approval from Jessa Hospital and Hasselt University (ethical committee reference 20.36-infecti20.05). The samples subjected to technical analysis (histochemistry, immunohistochemistry, DNA isolation and RNA isolation) consisted of anonymously collected spare tissue from three clinically indicated lung, liver and kidney surgery procedures at Jessa Hospital. No personal data were stored or processed with these samples. According to Belgian legislation, no informed consent is needed for use of spare tissue for technical validation of procedures implemented in a diagnostic pathology laboratory.
